References
1. Federal Scientific and Methodological Center for the Prevention and Control of AIDS FBUN of the Central Research Institute of Epidemiology of Rospotrebnadzor. Reference. HIV infection in the Russian Federation in 2017. (in Russian)
2. State Anti-Drug Committee. Report on the drug situation in the Russian Federation in 2018 (excerpt). 2019. (in Russian)
3. Yakovlev A.A., Diachkov A.G., Musatov V.B.,, Strelyanaya E.V., Mikitenko E.V., Gorodnicheva L.R. Prevalence rate and impact of addictive disorders on the course of Hiv-infection in in-patients. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Diseases]. 2017; 22 (6): 281–8. DOI: https://doi.org/10.18821/1560-9529-2017-22-6-281-288 (in Russian)
4. Petrosyan T.R., Shakhmardanov M.Z. HIV-infection and consumption of psychoactive substances. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Diseases]. 2018l; 23 (1): 60–7. DOI: https://doi.org/10.18821/1560-9529-2018-23-2-60-67 (in Russian)
5. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008; 1141: 105–30. DOI: https://doi.org/doi:10.1196/annals.1441.030
6. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990; 531 (1–2): 225–31. DOI: https://doi.org/10.1016/0006-8993(90)90778-A
7. Brunner R., Schaefer D., Hess K., Parzer P., Resch F., Schwab S. Effect of corticosteroids on short-term and long-term memory. Neurology. 2005; 64: 335–8. DOI: https://doi.org/10.1212/01.WNL.0000149523.35039.4C
8. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009; 30 (1): 65–91. DOI: https://doi.org/10.1016/j.yfrne.2008.11.002
9. Dong Y., Zheng P. Dehydroepiandrosterone sulphate: action and mechanism in the brain. J Neuroendocrinol. 2012; 24 (1): 215–24. DOI: https://doi.org/10.1111/j.1365-2826.2011.02256.x
10. Christeff N., Gherbi N., Mammes O., Dalle M.T., Gharakhanian S., Lortholary O., et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 1997; 22 (1): S11–8. DOI: https://doi.org/10.1016/S0306-4530(97)00015-2
11. Aggarwal J., Taneja R.S., Gupta P.K., Wali M., Chitkara A., Jamal A. Sex hormone profile in human immunodeficiency virus-infected men and it’s correlation with CD4 cell counts. Indian J Endocrinol Metab. 2018; 22: 328–34. DOI: https://doi.org/10.4103/ijem.IJEM_694_17
12. Wesson D.R., Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003; 35 (2): 253–9. DOI: https://doi.org/10.1080/02791072.2003.10400007
13. Heaton R.K., Marcotte T.D., Rivera Mindt M., Sadek J., Moore D.J., Bentley H., et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004; 10 (3): 317–31. DOI: https://doi.org/10.1017/S1355617704102130
14. Bryun E.A., Guekht A.B., Polunina A.G., Davydov D.M. Premorbid neuropsychological status in heroin abusers: impact on tolerance growth and treatment compliance. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Journal of Neurology and Psychiatry named after S.S. Korsakov]. 2002; 102 (6): 21–9. (in Russian)
15. Agibalova T.V., Poplevchenkov K.N. The state of cognitive functions in opiate addicted patients. Voprosy narkologii [Problems of Narcology]. 2012; (4): 62–73. (in Russian)
16. Kuznetsova O.A., Petrikov D.A. Structure and severity of cognitive changes in HIV-infected inpatients treated at AIDS Center. VICH infektsiya i immunosupressii [HIV Infection and Immunosuppression]. 2013; 5 (2): 52–7. (in Russian)
17. Vetlugina T.P., Nikitina V.B., Lobacheva O.A., Mandel A.I., Lyashenko G.P., Roshchina O.V. Cortisol and testosterone levels in alcoholic patients in withdrawal syndrome. Sibirskiy vestnik psikhiatrii i narkologii [Siberian Bulletin of Psychiatry and Narcology]. 2017; 3 (96): 5–10. (in Russian)
18. Gamaleya N.B. Immunotherapy for narcological diseases (part II). Voprosy narkologii [Problems of Narcology]. 2012; (1): 84–112. (in Russian)
19. Facchinetti F., Volpe A., Farci G., Petraglia F., Porro C.A., Barbieri G., et al. Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend. 1985; 15 (4): 361–6. DOI: https://doi.org/10.1016/0376-8716(85)90014-6
20. Kreek M.J., Wardlaw S.L., Hartman N., Raghunath J., Friedman J., Schneider B., et al. Circadian rhythms and levels of β-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci. 1983; 33: 409–11. DOI: https://doi.org/10.1016/0024-3205(83)90529-5
21. Katamanova E.V., Rukavishnikov V.S., Lakhman O.L., Shevchenko O.I., Denisova I.A. Cognitive impairment in a toxic lesion of the brain. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Journal of Neurology and Psychiatry named after S.S. Korsakov]. 2015; 115 (2): 11–5. DOI: https://doi.org/10.17116/jnevro20151152111-15 (in Russian)